Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial by Albain, Kathy S, Prof, Barlow, William E, Prof, Ravdin, Peter M, Prof, Farrar, William B, Prof, Burton, Gary V, Prof, Ketchel, Steven J, MD, Cobau, Charles D, MD, Levine, Ellis G, MD, Ingle, James N, Prof, Pritchard, Kathleen I, Prof, Lichter, Allen S, Prof, Schneider, Daniel J, MD, Abeloff, Martin D, Prof, Henderson, I Craig, Prof, Muss, Hyman B, Prof, Green, Stephanie J, Prof, Lew, Danika, MA, Livingston, Robert B, Prof, Martino, Silvana, DO, Osborne, C Kent, Prof

Get full text